BioNTech Net Debt from 2010 to 2024

BNTX Stock

USD 107.08 4.94 4.84%

BioNTech Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of BioNTech SE minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2018-12-31

Previous Quarter

-10.1 B

Current Value

-9.4 B

Quarterly Volatility

5.4 B

Covid

Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Tax Provision of 243 M, Net Interest Income of 367.2 M or Interest Income of 375.5 M, as well as many indicators such as Price To Sales Ratio of 5.77, Dividend Yield of 0.0111 or PTB Ratio of 1.2. BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.

Check out the analysis of BioNTech Correlation against competitors.

Latest BioNTech's Net Debt Growth Pattern

Below is the plot of the Net Debt of BioNTech SE over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. BioNTech's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioNTech's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

BioNTech Net Debt Regression Statistics

	Arithmetic Mean	(2,747,296,400)
	Coefficient Of Variation	(175.76)
	Mean Deviation	3,698,397,440
	Median	(277,011,000)
	Standard Deviation	4,828,533,395
	Sample Variance	23314734.7T
	Range	13.5B
	R-Value	(0.71)
	Mean Square Error	12401319.3T
	R-Squared	0.51
	Significance	0
	Slope	(768,089,318)
	Total Sum of Squares	326406286.4T

BioNTech Net Debt History

	2024	-10.9 B
	2023	-11.4 B
	2022	-13.7 B
	2021	-1.4 B
	2020	-970 M
	2019	-450.2 M
	2018	-357.3 M

Other Fundumenentals of BioNTech SE

Net Debt To E B I T D A

BioNTech Net Debt component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Long Term Investments	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	0.62	-0.93	0.99	0.94	0.68	0.82	0.76	0.86	0.75	1.0	0.67	0.81	0.67	1.0	1.0	0.86
Total Stockholder Equity	1.0		0.62	-0.95	1.0	0.95	0.64	0.83	0.78	0.84	0.78	0.99	0.63	0.83	0.66	1.0	1.0	0.85
Current Deferred Revenue	0.62	0.62		-0.53	0.6	0.8	0.26	0.79	0.74	0.49	0.72	0.59	0.46	0.78	0.72	0.62	0.6	0.85
Net Debt	-0.93	-0.95	-0.53		-0.95	-0.88	-0.43	-0.78	-0.72	-0.69	-0.74	-0.92	-0.37	-0.78	-0.58	-0.94	-0.94	-0.78
Retained Earnings	0.99	1.0	0.6	-0.95		0.95	0.6	0.85	0.8	0.81	0.8	0.99	0.59	0.84	0.62	1.0	0.99	0.83
Accounts Payable	0.94	0.95	0.8	-0.88	0.95		0.49	0.94	0.9	0.73	0.89	0.92	0.59	0.94	0.71	0.95	0.93	0.89
Net Receivables	0.68	0.64	0.26	-0.43	0.6	0.49		0.24	0.16	0.92	0.14	0.72	0.92	0.24	0.51	0.64	0.68	0.54
Good Will	0.82	0.83	0.79	-0.78	0.85	0.94	0.24		0.99	0.51	0.99	0.78	0.41	0.99	0.54	0.83	0.8	0.8
Short Term Investments	0.76	0.78	0.74	-0.72	0.8	0.9	0.16	0.99		0.43	1.0	0.71	0.35	0.99	0.46	0.77	0.74	0.73
Total Liab	0.86	0.84	0.49	-0.69	0.81	0.73	0.92	0.51	0.43		0.41	0.89	0.9	0.51	0.67	0.84	0.86	0.77
Long Term Investments	0.75	0.78	0.72	-0.74	0.8	0.89	0.14	0.99	1.0	0.41		0.71	0.31	0.99	0.45	0.77	0.74	0.71
Total Current Assets	1.0	0.99	0.59	-0.92	0.99	0.92	0.72	0.78	0.71	0.89	0.71		0.69	0.77	0.66	0.99	1.0	0.84
Short Term Debt	0.67	0.63	0.46	-0.37	0.59	0.59	0.92	0.41	0.35	0.9	0.31	0.69		0.41	0.6	0.63	0.65	0.64
Intangible Assets	0.81	0.83	0.78	-0.78	0.84	0.94	0.24	0.99	0.99	0.51	0.99	0.77	0.41		0.59	0.83	0.8	0.8
Common Stock	0.67	0.66	0.72	-0.58	0.62	0.71	0.51	0.54	0.46	0.67	0.45	0.66	0.6	0.59		0.66	0.66	0.84
Net Invested Capital	1.0	1.0	0.62	-0.94	1.0	0.95	0.64	0.83	0.77	0.84	0.77	0.99	0.63	0.83	0.66		1.0	0.86
Net Working Capital	1.0	1.0	0.6	-0.94	0.99	0.93	0.68	0.8	0.74	0.86	0.74	1.0	0.65	0.8	0.66	1.0		0.85
Capital Stock	0.86	0.85	0.85	-0.78	0.83	0.89	0.54	0.8	0.73	0.77	0.71	0.84	0.64	0.8	0.84	0.86	0.85

Click cells to compare fundamentals

About BioNTech Financial Statements

BioNTech investors use historical fundamental indicators, such as BioNTech's Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioNTech. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	-11.4 B	-10.9 B
Net Debt To EBITDA	(10.52)	(10.00)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioNTech Net Debt from 2010 to 2024

Latest BioNTech's Net Debt Growth Pattern

BioNTech Net Debt Regression Statistics

BioNTech Net Debt History

Other Fundumenentals of BioNTech SE

BioNTech Net Debt component correlations

About BioNTech Financial Statements

Also Currently Popular

Additional Tools for BioNTech Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY